Israel vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Immunization, Hib3
Immunization, Hib3 over time
- Israel
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
How they compare
Israel currently reports 98.0% against 83.7% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 14.3%.
That makes Israel's figure about 1.2 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.
Across all 31 years both countries report, Israel has been ahead every year.
Israel ranks 20th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 20th of 191 countries.
Israel has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Israel | Middle East, North Africa, Afghanistan & Pakistan (excluding high income) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 92.7% | 0.0% | 92.7% | Israel |
| 2000s | 93.8% | 11.8% | 82.0% | Israel |
| 2010s | 95.7% | 68.1% | 27.6% | Israel |
| 2020s | 98.0% | 82.6% | 15.4% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Israel or Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- Israel, at 98.0% against 83.7% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2024.
- What is the difference in immunization, hib3 between Israel and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 14.3%, with Israel ahead.
- How many years of comparable data are there for Israel and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 31 years are reported by both, from 1994 to 2024.
- How do Israel and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank globally for immunization, hib3?
- Israel ranks 20th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 20th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.